Kom igång
L&G PHARMA BREAKTHROUGH UCITS ETFL&G PHARMA BREAKTHROUGH UCITS ETFL&G PHARMA BREAKTHROUGH UCITS ETF

L&G PHARMA BREAKTHROUGH UCITS ETF

Inga transaktioner
Se i superdiagram
Översikt
Analys Nyheter Idéer

ETLI diagram

Nyckeltal

Assets under management (AUM)
‪16.58 M‬EUR
Fund flows (1Y)
—
Dividend yield (indicated)
—
Discount/Premium to NAV
—

Om L&G PHARMA BREAKTHROUGH UCITS ETF

Issuer
Legal & General Group Plc
Brand
L&G
Expense ratio
0.49%
Home page
fundcentres.lgim.com
Inception date
23 jan. 2018
Index tracked
Solactive Pharma Breakthrough Value Index
Management style
Passive
ISIN
IE00BF0H7608

Classification

Asset Class
Equity
Kategori
Sektor
Focus
Sjukvård
Niche
Apotek
Strategi
Multifaktor
Weighting scheme
Lika
Selection criteria
Multifaktor

Analys

What's in the fund
Exposure type
AktierBonds, Cash & Other
Hälsoteknik
Stock breakdown by region
2%47%19%30%

Nyheter

Läs mer